-1::1
Simple Hit Counter
Skip to content

Products

Solutions

×
×
Sign In

EN

EN - EnglishCN - 简体中文DE - DeutschES - EspañolKR - 한국어IT - ItalianoFR - FrançaisPT - Português do BrasilPL - PolskiHE - עִבְרִיתRU - РусскийJA - 日本語TR - TürkçeAR - العربية
Sign In Start Free Trial

RESEARCH

JoVE Journal

Peer reviewed scientific video journal

Behavior
Biochemistry
Bioengineering
Biology
Cancer Research
Chemistry
Developmental Biology
View All
JoVE Encyclopedia of Experiments

Video encyclopedia of advanced research methods

Biological Techniques
Biology
Cancer Research
Immunology
Neuroscience
Microbiology
JoVE Visualize

Visualizing science through experiment videos

EDUCATION

JoVE Core

Video textbooks for undergraduate courses

Analytical Chemistry
Anatomy and Physiology
Biology
Cell Biology
Chemistry
Civil Engineering
Electrical Engineering
View All
JoVE Science Education

Visual demonstrations of key scientific experiments

Advanced Biology
Basic Biology
Chemistry
View All
JoVE Lab Manual

Videos of experiments for undergraduate lab courses

Biology
Chemistry

BUSINESS

JoVE Business

Video textbooks for business education

Accounting
Finance
Macroeconomics
Marketing
Microeconomics

OTHERS

JoVE Quiz

Interactive video based quizzes for formative assessments

Authors

Teaching Faculty

Librarians

K12 Schools

Biopharma

Products

RESEARCH

JoVE Journal

Peer reviewed scientific video journal

JoVE Encyclopedia of Experiments

Video encyclopedia of advanced research methods

JoVE Visualize

Visualizing science through experiment videos

EDUCATION

JoVE Core

Video textbooks for undergraduates

JoVE Science Education

Visual demonstrations of key scientific experiments

JoVE Lab Manual

Videos of experiments for undergraduate lab courses

BUSINESS

JoVE Business

Video textbooks for business education

OTHERS

JoVE Quiz

Interactive video based quizzes for formative assessments

Solutions

Authors
Teaching Faculty
Librarians
<<<<<<< HEAD
K12 Schools
Biopharma
=======
K12 Schools
>>>>>>> dee1fd4 (fixed header link)

Language

English

EN

English

CN

简体中文

DE

Deutsch

ES

Español

KR

한국어

IT

Italiano

FR

Français

PT

Português do Brasil

PL

Polski

HE

עִבְרִית

RU

Русский

JA

日本語

TR

Türkçe

AR

العربية

    Menu

    JoVE Journal

    Behavior

    Biochemistry

    Bioengineering

    Biology

    Cancer Research

    Chemistry

    Developmental Biology

    Engineering

    Environment

    Genetics

    Immunology and Infection

    Medicine

    Neuroscience

    Menu

    JoVE Encyclopedia of Experiments

    Biological Techniques

    Biology

    Cancer Research

    Immunology

    Neuroscience

    Microbiology

    Menu

    JoVE Core

    Analytical Chemistry

    Anatomy and Physiology

    Biology

    Cell Biology

    Chemistry

    Civil Engineering

    Electrical Engineering

    Introduction to Psychology

    Mechanical Engineering

    Medical-Surgical Nursing

    View All

    Menu

    JoVE Science Education

    Advanced Biology

    Basic Biology

    Chemistry

    Clinical Skills

    Engineering

    Environmental Sciences

    Physics

    Psychology

    View All

    Menu

    JoVE Lab Manual

    Biology

    Chemistry

    Menu

    JoVE Business

    Accounting

    Finance

    Macroeconomics

    Marketing

    Microeconomics

Start Free Trial
Loading...
Home
JoVE Journal
Biology
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intr...
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intr...
JoVE Journal
Biology
This content is Free Access.
JoVE Journal Biology
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds

Full Text
3,229 Views
06:36 min
September 8, 2021

DOI: 10.3791/62903-v

Josselin Rigaill*1,2, Estelle Audoux*1, Killian Rodriguez1, Aurélien Peyron1, Philippe Berthelot1,3, Jérôme Josse4,5, Frédéric Laurent4,5, Robin Caire1, Paul O. Verhoeven1,2

1CIRI, Centre International de Recherche en Infectiologie, GIMAP team,University of Lyon, INSERM U1111, CNRS, UMR5308, ENS Lyon, UCBL1, University of St-Etienne, France, 2Department of Infectious Agents and Hygiene,University Hospital of St-Etienne, St-Etienne, France, 3Department of Infectious Diseases,University Hospital of St-Etienne, St-Etienne, France, 4CIRI, Centre International de Recherche en Infectiologie, Staphylococcal Pathogenesis team,University of Lyon, INSERM U1111, CNRS UMR5308, ENS Lyon, UCBL1, University of Lyon, Lyon, France, 5Department of Bacteriology, Institute for Infectious Agents,Hospices Civils de Lyon, Lyon, France

Overview

This study focuses on understanding the internalization of Staphylococcus aureus in human host cells and its survival mechanisms within those cells. Additionally, it evaluates the effectiveness of various antimicrobial compounds against this bacterium using an enhanced enzyme protection assay.

Key Study Components

Research Area

  • Microbial pathogenesis
  • Antimicrobial response
  • Cellular internalization dynamics

Background

  • Staphylococcus aureus poses significant clinical challenges due to its ability to survive within host cells.
  • Understanding its internalization can inform treatment strategies against infections.
  • Previous methods may have limitations in accurately quantifying bacterial internalization.

Methods Used

  • Improved enzyme protection assay for studying bacterial internalization
  • A549 epithelial cells for host cell model
  • Fluorescence microscopy, lysostaphin treatment, and colony counting techniques

Main Results

  • Mean intracellular loads of Staphylococcus aureus were significantly quantified using the improved assay.
  • Varied efficacy of antimicrobial compounds, with vancomycin showing higher intracellular activity.
  • The modified protocol facilitated more accurate measurement of bacterial internalization.

Conclusions

  • The study presents an effective method for quantifying Staphylococcus aureus survival in host cells.
  • This research offers insights vital for developing treatment strategies against bacterial infections.

Frequently Asked Questions

What is Staphylococcus aureus?
Staphylococcus aureus is a common bacterium that can cause a range of infections in humans, from mild skin infections to more severe conditions.
Why is studying intracellular survival important?
Studying how bacteria survive within cells can help develop better treatment strategies and understand infection mechanisms.
What is an enzyme protection assay?
It is a method used to quantify the number of bacteria that have been internalized within host cells and can survive after treatment.
What cell line was used in this study?
The A549 epithelial cell line was used as a model to study Staphylococcus aureus interaction.
How does the improved enzyme protection assay work?
It simplifies recovering internalized bacteria and minimizes the loss of infected cells during the process.
Which antimicrobial compounds were tested?
Vancomycin, rifampicin, and levofloxacin were tested for their effectiveness against intracellular Staphylococcus aureus.
What were the findings regarding antimicrobial efficacy?
The study found varying levels of efficacy among the tested compounds, particularly noting the relatively high intracellular activity of vancomycin.

This protocol aims to describe how to study the extent of Staphylococcus aureus internalization and its ability to survive inside the human host cell, as well as the intracellular efficacy of antimicrobial compounds.

The enzyme protection assay enable to study the extent of Staph aureus internalization and its ability to survive inside adherent cells, as well as the efficacy of antimicrobial compound. The improved enzyme protection assay greatly simplifies technical handling, and enable to recover internalized bacteria from weakly-adherent cells and cells in suspension. Demonstrating the procedure will be Josselin Rigaill, medical doctor and PhD student from my laboratory.

Two days before the infection assay, seed A549 epithelial cells at a density of 2.0 times 10 to the fifth cells per milliliter per well of a 24-well plate and incubate the cells for 48 hours at 36 degrees Celsius in 5%carbon dioxide, until they reach 100%confluence. On the day of the assay, remove and discard the spent culture medium from the three wells dedicated for counting the A549 cells, and add one milliliter of complete infection medium containing five micrograms per milliliter of Hoechst 33342 and one microgram per milliliter of propidium iodide. Incubate the cells for 30 minutes, then, using a wide-field fluorescence microscope, count the number of cells and calculate the cell viability.

To prepare the bacterial suspension, dispense 25 milliliters of complete infection medium in a tube, and prewarm it at 36 degrees Celsius. Next, adjust the Staphylococcus aureus suspension to an OD of 0.5 in a complete infection medium using a cell density meter, then prepare 20 milliliters of bacterial suspension for cell inoculation by diluting the culture in a complete infection medium to achieve an MOI of one according to the number of cells per well. Next, using an automatic spiral plater, determine the Staphylococcus aureus load of the diluted bacterial suspension to be used for the cell inoculation step, and incubate the agar plates for 18 to 24 hours at 36 degrees Celsius.

The next day, count the number of colonies with a colony counter to calculate the accurate MOI for each strain tested. Before cell inoculation, observe every well of the 24-well plate by low magnification microscopy to ensure that the cells are healthy and growing as expected, then remove and discard the spent cell culture medium from the 24-well plate and add 500 microliters of the bacterial suspension to each well containing 100%confluent cells. Incubate the cells for two hours at 36 degrees Celsius in 5%carbon dioxide.

To quantify the intracellular bacteria with the improved enzyme protection assay, prepare 4x lysis buffer, 2%Triton X-100, trypsin-EDTA, and lysostaphin stock in working solutions as mentioned in the text manuscript. Next, prepare 6.25 milliliters of complete infection medium supplemented with lysostaphin by adding six milliliters of complete infection medium to 250 microliters of the lysostaphin working solution. Then, add 250 microliters of the complete infection medium supplemented with lysostaphin into each well and gently agitate the plate by swiveling the plate by hand.

To allow the lysostaphin to kill the extracellular bacteria, incubate the cells for one hour at 36 degrees Celsius in 5%carbon dioxide, then inactivate the lysostaphin by adding 10 microliters of proteinase K at 20 micrograms per milliliter into each well and incubating the cells for two minutes at room temperature. Next, add 250 microliters of 4x lysis buffer to lyse the cells by osmotic shock, and incubate the cells for 10 minutes at 36 degrees Celsius. After the incubation, pipette the cell lysate up and down several times to ensure that the cells are fully lysed and homogenized, then use an automatic spiral plater to determine the Staphylococcus aureus load of each well and incubate the agar plates for 18 to 24 hours at 36 degrees Celsius.

The next day, count the number of colonies with a colony counter to calculate the intracellular Staphylococcus aureus load of each well. The internalization of two strains of Staphylococcus aureus by A549 epithelial cells is depicted here. Using the enzyme protection assay that includes washes to remove lysostaphin, the mean intracellular loads were 4.46 and 0.49 log cfu per milliliter for the SF8300 wild type and the isogenic mutant lacking the fnbA and B genes, respectively.

Using the improved enzyme protection assay that uses proteinase K to inactivate lysostaphin, the loads were 4.53 and 0.56 log cfu per milliliter, respectively. Intracellular activity of vancomycin, rifampicin, and levofloxacin against Staphylococcus aureus measured using enzyme protection assay is depicted here. The mean intracellular loads were 4.57 log cfu per milliliter for control, 4.51 for vancomycin, 3.03 for rifampicin and 2.91 for levofloxacin.

Intensive washes to remove the enzyme tend to detach the most infected cells, which can give inaccurate results and support the use of the improved protocol. The improved enzyme protection assay make it easier to study Staph aureus internalization with organoid, and can be easily adapted on high content screening system that's used by putting

View the full transcript and gain access to thousands of scientific videos

Sign In Start Free Trial

Explore More Videos

Enzyme Protection AssayStaphylococcus AureusInternalizationAntimicrobial CompoundsA549 Epithelial CellsFluorescence MicroscopyCell ViabilityBacterial SuspensionMOI (multiplicity Of Infection)Colony CountingInfection MediumPhD ResearchLow Magnification Microscopy

Related Videos

Lysostaphin-Based Enzyme Protection Assay: An In Vitro Method to Quantify Intracellular  Staphylococcus aureus  Load by Enzyme-Mediated Selective Killing of Extracellular Bacteria

04:04

Lysostaphin-Based Enzyme Protection Assay: An In Vitro Method to Quantify Intracellular Staphylococcus aureus Load by Enzyme-Mediated Selective Killing of Extracellular Bacteria

Related Videos

698 Views

Cytotoxicity Assay of Staphylococcus aureus Strains on Neutrophils following Phagocytosis

03:35

Cytotoxicity Assay of Staphylococcus aureus Strains on Neutrophils following Phagocytosis

Related Videos

537 Views

Stress-induced Antibiotic Susceptibility Testing on a Chip

12:41

Stress-induced Antibiotic Susceptibility Testing on a Chip

Related Videos

6.8K Views

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials

10:50

Qualitative and Quantitative Assays for Detection and Characterization of Protein Antimicrobials

Related Videos

19K Views

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

10:00

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Related Videos

13.8K Views

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition

07:42

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition

Related Videos

15.5K Views

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Related Videos

18.5K Views

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Related Videos

8.3K Views

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Related Videos

6.8K Views

Standardized In vitro Assays to Visualize and Quantify Interactions between Human Neutrophils and Staphylococcus aureus Biofilms

07:28

Standardized In vitro Assays to Visualize and Quantify Interactions between Human Neutrophils and Staphylococcus aureus Biofilms

Related Videos

3K Views

JoVE logo
Contact Us Recommend to Library
Research
  • JoVE Journal
  • JoVE Encyclopedia of Experiments
  • JoVE Visualize
Business
  • JoVE Business
Education
  • JoVE Core
  • JoVE Science Education
  • JoVE Lab Manual
  • JoVE Quizzes
Solutions
  • Authors
  • Teaching Faculty
  • Librarians
  • K12 Schools
  • Biopharma
About JoVE
  • Overview
  • Leadership
Others
  • JoVE Newsletters
  • JoVE Help Center
  • Blogs
  • Site Maps
Contact Us Recommend to Library
JoVE logo

Copyright © 2026 MyJoVE Corporation. All rights reserved

Privacy Terms of Use Policies
WeChat QR code